# Fluorescent Probe for Assessment of Renal Elimination

> **NCT07643467** · PHASE4 · RECRUITING · sponsor: **Aaron Cook** · enrollment: 200 (estimated)

## Conditions studied

- Augmented Renal Clearance
- Critical Illness

## Interventions

- **DRUG:** Relmapirazin
- **DRUG:** Iohexol
- **DEVICE:** Medibeacon tGFR monitor
- **DIAGNOSTIC_TEST:** Urine creatinine clearance collection

## Key facts

- **NCT ID:** NCT07643467
- **Lead sponsor:** Aaron Cook
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643467, "Fluorescent Probe for Assessment of Renal Elimination". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*